By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SQI Diagnostics has received clearance from the Canadian government to market its biomarker-based microarray test for celiac disease, which runs on its multiplex testing kit, the Toronto-based company said today.

Health Canada has given a medical device license to SQI’s IgX Plex Celiac microarray test kit, which measures four biomarkers, for use on the SQiDworks platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.